💊 What is Spegra Tablet?

Spegra Tablet is a prescription antiretroviral product containing three active ingredients in one tablet. It is intended for use in a clinically supervised HIV treatment plan. The product should not be selected, started, stopped or substituted based only on an online article, a search result, an AI answer, a friend’s experience or a previous prescription that is no longer current.

HIV treatment is not the same for every person. Two people with HIV may receive different combinations because the doctor may need to consider prior exposure to antiretroviral medicines, possible drug resistance, other health conditions, pregnancy or breastfeeding, hepatitis B infection, kidney function, liver function and medicines used for tuberculosis, seizures or other conditions.

A fixed-dose combination can make a prescribed regimen easier to follow because more than one active antiretroviral ingredient is provided in a single tablet. This convenience does not mean the tablet is suitable for everyone, and it does not remove the need for viral-load testing, medical follow-up or adherence support.

Before ordering, compare the product name, strength, composition, manufacturer, batch number, expiry date and packaging with your prescription and the medicine pack. If any information does not match, contact a pharmacist or doctor before taking the tablet.

🧪 Spegra Tablet composition

The confirmed composition supplied for this product is:

Strengths and ingredients should always be checked against the physical pack and current manufacturer leaflet. Excipients, tablet appearance, pack size, storage instructions and manufacturer information may vary by product presentation or market. Do not rely on a product title alone when verifying a medicine.

Spegra contains three different antiretroviral components, but it should not automatically be described as a complete regimen for every patient. Whether it is used alone as a prescribed fixed-dose regimen or alongside another medicine is a clinical decision. The treating HIV doctor must confirm the complete regimen.

🎯 What is Spegra Tablet used for?

Spegra may be prescribed for the treatment of HIV-1 infection in appropriate patients. The objective of antiretroviral therapy is to suppress HIV replication, reduce the amount of virus in the blood, support immune function and lower the risk of HIV-related illness. Treatment also supports long-term health when it is taken consistently and monitored properly.

The exact approved use, age or weight criteria and regimen instructions should be confirmed from the current local product information for the exact Spegra pack. A product page should not invent an age limit, weight limit or regulatory indication. Patients and healthcare professionals should use the approved label, prescribing information and current national HIV guidelines when making treatment decisions.

Spegra is not an antibiotic, painkiller, vitamin or general immune booster. It is not intended to treat ordinary viral fever, influenza or unrelated infections. It is also not a cure for HIV or AIDS. A patient who feels well must continue treatment as prescribed unless the doctor changes it.

How doctors decide whether it is appropriate

Before prescribing or switching to a dolutegravir, emtricitabine and tenofovir alafenamide combination, a doctor may review the patient’s HIV diagnosis, current and previous regimens, adherence history, treatment response, viral load, CD4 count, resistance testing, hepatitis B status, kidney function, liver function and other medicines. The doctor may also ask about pregnancy, pregnancy planning, breastfeeding, allergies, mental-health symptoms, bone health and previous serious medicine reactions.

A person should not buy Spegra simply because the composition resembles a tablet used by someone else. Similar-sounding HIV products can have different strengths, different ingredients or different treatment roles. Always use the exact prescription issued for the individual patient.

🔬 How does Spegra work?

HIV uses several enzymes and stages to reproduce itself inside infected cells. Spegra combines medicines that act on different parts of this process.

Dolutegravir

Dolutegravir is an integrase strand transfer inhibitor, often shortened to an integrase inhibitor. HIV integrase helps the virus insert its genetic material into the DNA of a human cell. Dolutegravir blocks this process, making it more difficult for HIV to continue its replication cycle.

Emtricitabine

Emtricitabine is a nucleoside reverse transcriptase inhibitor. HIV reverse transcriptase helps the virus convert its genetic information into a form it can use during replication. Emtricitabine interferes with this process and helps reduce the production of new virus.

Tenofovir alafenamide

Tenofovir alafenamide is a prodrug. It is converted inside the body into an active tenofovir component that inhibits reverse transcriptase. Its activity complements emtricitabine’s activity against viral replication. Because the combination affects HIV at more than one stage, it is important to take it consistently and avoid unplanned treatment gaps.

Suppressing HIV does not remove every copy of the virus from the body. This is why treatment is generally long term and why doctors continue to monitor viral load, immune status, tolerability and safety laboratory results.

✅ Potential benefits of prescribed Spegra treatment

When prescribed for the right patient and taken as directed, the combination may provide the following treatment benefits:

• HIV viral-load suppression: it can help reduce HIV replication and lower the amount of HIV in the blood.
• Support for immune health: sustained treatment can help protect or restore immune function, which is assessed through clinical review and tests such as CD4 count.
• Reduced risk of HIV-related complications: effective antiretroviral therapy can reduce the risk of illnesses associated with uncontrolled HIV.
• Convenience of a fixed-dose combination: three active components are supplied in one tablet, which may simplify the doctor-prescribed regimen.
• Long-term treatment support: consistent viral suppression is associated with better long-term HIV management than irregular or interrupted treatment.

These are potential treatment benefits, not guarantees. Results depend on the individual’s HIV strain, resistance profile, adherence, absorption, other medicines, immune status and overall healthcare plan. A patient should not judge effectiveness by symptoms alone. Many people with HIV feel well even when viral load is not controlled, so laboratory monitoring remains important.

🕒 How to take Spegra Tablet

Take Spegra exactly as prescribed by the HIV doctor. Do not choose the dose from an online dosage calculator and do not change the schedule when symptoms improve. The doctor may prescribe one tablet at a specific time, but the correct instruction for the individual patient is the prescription and current pack leaflet.

• Swallow the tablet with water.
• Do not chew, crush or split it unless a doctor or pharmacist specifically confirms that this is appropriate for the exact product.
• It may be taken with or without food if that is consistent with the current product information and prescription.
• Try to take it at the same time each day to support adherence.
• Do not share the tablet with another person, even if they have HIV or similar symptoms.
• Keep enough medicine available before travelling, holidays or weekends.

Why daily adherence matters

Antiretroviral medicines work best when their levels remain consistent. Missed doses or repeated treatment interruptions can allow HIV to multiply and may increase the risk of resistance. Resistance can make some medicines less effective and can complicate future treatment choices. If a patient is struggling with nausea, cost, stigma, travel, forgetfulness, mood symptoms or access to refills, the best response is to tell the HIV care team early rather than silently stopping therapy.

Do not double the dose

Taking extra tablets does not safely compensate for missed doses and may increase the risk of adverse effects. If too much Spegra has been taken, contact a doctor, pharmacist or emergency service and keep the medicine pack available for identification.

⏰ What to do if a Spegra dose is missed

If a patient remembers a missed dose with enough time before the next scheduled dose, the missed dose may generally be taken when remembered. If the next dose is close, the missed dose is usually skipped and the normal schedule is resumed. Do not take two doses together unless a qualified clinician gives that specific instruction.

Instructions can differ depending on when the dose was missed, whether vomiting occurred and what other medicines are being taken. Patients who miss doses frequently, run out of tablets or cannot keep the medicine down should contact their HIV clinic or pharmacist for individual advice.

If vomiting occurs soon after taking the tablet, do not automatically repeat the dose. Ask the doctor or pharmacist what to do, because the correct action depends on timing and the likelihood that the medicine was absorbed.

⚠️ Spegra Tablet side effects

Not every patient experiences side effects. Some effects are mild and temporary, while others require medical assessment. The following information is not a complete list and should be read together with the exact package leaflet.

Possible common or less serious effects

• Headache
• Nausea or stomach discomfort
• Diarrhoea
• Tiredness or weakness
• Dizziness
• Sleep disturbance or insomnia
• Abnormal dreams or mood changes
• Changes in weight or appetite

Report persistent, severe or worsening symptoms to the treating doctor. Patients should not stop antiretroviral treatment just because a mild symptom appears, but they should not ignore symptoms that are severe or unusual.

Seek urgent medical attention for

• Rapidly spreading rash, blistering, skin peeling or rash with fever
• Swelling of the face, lips, tongue or throat, wheezing or difficulty breathing
• Severe weakness, fainting, confusion or unusual drowsiness
• Yellow skin or eyes, very dark urine, pale stools or severe abdominal pain
• Persistent vomiting, severe diarrhoea or signs of dehydration
• Severe muscle pain, unusual weakness or reduced urine output
• New severe depression, suicidal thoughts or serious changes in behaviour

Important risks doctors may monitor

Depending on the patient, doctors may monitor liver function, kidney function, body weight, bone health, hepatitis B activity and other clinical parameters. Rare but important reactions associated with antiretroviral therapy can include hypersensitivity reactions, liver injury, kidney-related problems, changes in bone mineral density, immune reconstitution inflammatory syndrome and lactic acidosis. The actual risk varies by patient and should be interpreted by a healthcare professional.

🔄 Spegra drug interactions

Tell the HIV doctor and pharmacist about every medicine, supplement and traditional or herbal product being used. This includes medicines purchased without a prescription and products used only occasionally. The following interaction groups are particularly important:

Dofetilide

Dolutegravir may interact significantly with dofetilide. Concomitant use may be contraindicated. A patient taking dofetilide must tell the doctor before Spegra is prescribed.

Rifampicin and tuberculosis treatment

Rifampicin and some other medicines used for tuberculosis can reduce dolutegravir exposure. The HIV and TB doctors may need to choose a different regimen or adjust the timing or dose according to approved guidance. Never make this adjustment independently.

Anticonvulsants

Carbamazepine, phenytoin, phenobarbital and some other enzyme-inducing anticonvulsants can reduce levels of antiretroviral medicines. The doctor must review seizure medicines before prescribing or changing Spegra.

Antacids and mineral supplements

Products containing aluminium, magnesium, calcium or iron can affect dolutegravir absorption when taken too close together. This includes some antacids, multivitamins, iron tablets and calcium supplements. The correct separation interval depends on the product and prescription, so ask a pharmacist for an exact schedule.

Metformin

Dolutegravir can increase metformin exposure in some patients. People with diabetes should tell the doctor about metformin use. The doctor may consider kidney function, blood-glucose monitoring and whether a dose adjustment is required.

St John’s wort

St John’s wort may lower antiretroviral exposure and should not be used with Spegra unless the treating clinician specifically confirms it is appropriate. Herbal does not mean interaction-free.

Other medicines

Other interactions may involve medicines for HIV, hepatitis, infections, seizures, mental health, heart conditions, cancer, high cholesterol or stomach problems. Bring a current medicine list or photographs of all medicine packs to every consultation.

🩺 Important precautions for special situations

Kidney disease

Tell the doctor about kidney disease, dialysis, abnormal creatinine results, a history of kidney stones or medicines that may affect the kidneys. Tenofovir-containing products require appropriate clinical consideration and monitoring. Suitability depends on the exact level of kidney function and the patient’s complete medical history. Do not describe Spegra as automatically safe or automatically unsafe for every person with kidney disease.

Liver disease and hepatitis B

Tell the doctor about hepatitis B, hepatitis C, cirrhosis, fatty liver, abnormal liver tests or previous jaundice. Emtricitabine and tenofovir alafenamide have activity against hepatitis B, but treatment decisions must be made as part of a complete HIV and HBV plan. Stopping a medicine with anti-HBV activity can cause hepatitis B flare or worsening in some patients. Spegra must not be stopped suddenly without medical supervision.

Pregnancy and pregnancy planning

Patients who are pregnant, planning pregnancy or breastfeeding should discuss Spegra with an HIV specialist. Dolutegravir-containing treatment may be appropriate in many clinical situations, but the decision must consider current guidance, the exact product information, pregnancy stage, viral load, other medicines and the benefits of maintaining effective viral suppression. Never start, stop or switch antiretroviral therapy without medical advice.

Breastfeeding

HIV transmission, the local infant-feeding recommendation and the patient’s treatment plan must be discussed with a qualified healthcare professional. Do not use an online product page to make an infant-feeding decision.

Children and adolescents

Children and adolescents require age-appropriate and weight-appropriate HIV treatment. The approved age and weight criteria can differ between products and markets. Do not give an adult tablet to a child based on a general internet recommendation. A paediatric HIV specialist must verify the exact pack, dose and formulation.

Mental health

Tell the doctor about depression, anxiety, insomnia, suicidal thoughts or previous psychiatric illness. Mood and sleep changes can have many causes, including HIV, stress, other medicines and antiretroviral treatment. Severe or new suicidal thoughts require urgent help.

🚨 Spegra, PEP and PrEP: an important clarification

Do not use Spegra on your own as PEP or PrEP. PEP, or post-exposure prophylaxis, is an urgent medical intervention after a possible HIV exposure. It must be started as soon as possible within the clinically recommended time window and uses a healthcare-professional-selected regimen after risk assessment and testing.

PrEP, or pre-exposure prophylaxis, is prevention medicine for people who do not have HIV but may have ongoing exposure risk. PrEP requires HIV testing, medical assessment, follow-up and an approved medicine or regimen for that purpose. A medicine prescribed for HIV treatment should not automatically be marketed as PrEP.

If a person has had a possible exposure, they should seek urgent medical care rather than waiting for delivery or taking leftover tablets. An online product page cannot assess exposure risk, HIV status, hepatitis status, pregnancy or drug interactions.

🧬 Viral suppression and HIV transmission

Effective antiretroviral treatment can reduce HIV viral load to very low or undetectable levels. When viral suppression is confirmed and maintained under medical care, the risk of sexual transmission is dramatically reduced. This is a clinical outcome that requires adherence, testing and medical confirmation; it should not be presented as an instant guarantee after taking one tablet.

Spegra does not protect against sexually transmitted infections and does not replace condoms, testing, partner communication, prevention counselling or other advice from a healthcare professional. It also does not prevent pregnancy. Patients should follow the complete prevention plan recommended by their doctor.

📋 Tests and follow-up during HIV treatment

Regular follow-up helps the care team confirm whether treatment is working and whether it remains safe. Depending on the patient, the doctor may monitor:

• HIV viral load
• CD4 count or other immune-status measures
• Kidney function and urine findings
• Liver function
• Hepatitis B and hepatitis C status
• Drug-resistance testing when clinically indicated
• Body weight, blood glucose and lipid profile when appropriate
• Bone health when risk factors are present
• Adherence, side effects and mental wellbeing

A patient should keep appointments even when they feel healthy. Treatment response cannot be judged accurately from symptoms alone.

🍽️ Food, alcohol and daily routine

Follow the current pack leaflet and your prescription regarding food. Many patients are able to take the tablet with or without food, but interactions with mineral supplements and antacids require special attention. Ask the pharmacist about the timing of calcium, iron, magnesium and aluminium-containing products.

Alcohol is not a substitute for medical advice. People with liver disease, hepatitis or other medicines should ask their doctor about alcohol. If dizziness, unusual tiredness, sleep disturbance or concentration problems occur, avoid driving or operating machinery until medically assessed.

Helpful adherence habits include taking the tablet at the same time each day, using a reminder, keeping a small supply plan for travel and arranging refills before the medicine runs out. Store the medicine privately and securely if privacy is a concern, but do not hide side effects or missed doses from the care team.

📦 How to store Spegra Tablet

• Keep it in the original container or blister pack.
• Follow the storage temperature and moisture instructions printed on the pack.
• Protect it from excessive heat, direct sunlight and moisture.
• Keep the container closed and out of reach of children and pets.
• Do not use tablets after the expiry date or tablets with damaged, wet or suspicious packaging.
• Ask a pharmacist how to dispose of unused or expired tablets safely.

🛒 Buying Spegra safely online

Prescription HIV medicines require careful sourcing and handling. Before placing an order, check that the seller requests a valid prescription where required and provides a proper invoice. When the package arrives, compare the product name, composition, strength, manufacturer, batch number, expiry date, seal and tablet presentation with the prescription and pack information.

Do not purchase a pack with a broken seal, missing batch details, altered printing, unusual spelling, unexplained price difference or packaging that does not match the manufacturer’s information. Do not take a medicine simply because the listing has a large discount or claims to be “100% safe.” If authenticity is uncertain, do not use the medicine until a pharmacist verifies it.

Prices, MRP, stock status, delivery availability, return rules and prescription requirements can change. The store should display only information verified against current inventory, the actual product pack and its current medicine policy.

❓ Spegra Tablet FAQs

1. What is Spegra Tablet?

Spegra Tablet is a prescription antiretroviral medicine containing dolutegravir 50 mg, emtricitabine 200 mg and tenofovir alafenamide 25 mg. It is used under medical supervision as part of an HIV-1 treatment plan.

2. What are the salts in Spegra Tablet?

The confirmed active components are dolutegravir 50 mg, emtricitabine 200 mg and tenofovir alafenamide 25 mg per tablet. Always verify the strength on the actual pack because medicine presentations can vary.

3. What is Spegra used for?

It may be prescribed for the treatment of HIV-1 infection. The doctor decides whether it is appropriate and whether it is used as a complete prescribed regimen or with another antiretroviral medicine.

4. Does Spegra cure HIV?

No. Spegra can suppress HIV replication and support long-term HIV management, but it does not remove HIV from the body or provide a complete cure. Treatment must continue as prescribed.

5. Is Spegra an antibiotic?

No. Spegra is an antiretroviral medicine. It works against HIV and is not a general antibiotic or treatment for common bacterial infections.

6. Is Spegra a complete HIV regimen?

Do not assume this from the product name. The prescribing doctor decides the complete regimen after reviewing treatment history, resistance, viral load, hepatitis B status and other clinical factors.

7. How often is Spegra taken?

The doctor may prescribe it once daily, but patients must follow their individual prescription and pack leaflet. Never change frequency or dose without medical advice.

8. Should Spegra be taken with food?

Follow the current product information and the prescription. Many patients may take it with or without food, but antacids and mineral supplements can require special timing.

9. Can Spegra be taken at night?

The best time is the time prescribed by the doctor that the patient can follow consistently. If the medicine causes insomnia, vivid dreams or dizziness, discuss timing with the doctor rather than changing it independently.

10. What happens if I miss a Spegra dose?

Take it when remembered unless the next dose is close; in that case, skip the missed dose and resume the normal schedule. Do not double the dose. Ask a pharmacist for individual advice if doses are missed often.

11. Can I stop Spegra when my viral load becomes undetectable?

No. An undetectable viral load usually means the treatment is working; it does not mean HIV has disappeared. Stopping without medical supervision can allow the virus to return and may increase resistance risk.

12. Can Spegra be used for PEP?

Do not self-use Spegra as PEP. PEP is an urgent post-exposure treatment selected after medical assessment, HIV testing and interaction review. Seek urgent care after a possible exposure.

13. Can Spegra be used for PrEP?

Do not use it as PrEP without a specialist’s prescription. PrEP is prevention for people who do not have HIV and requires testing, risk assessment and an approved prevention protocol.

14. Does Spegra prevent HIV transmission immediately?

No medicine should be marketed as providing instant guaranteed prevention after one dose. Sustained viral suppression requires regular treatment, adherence and laboratory confirmation. Follow the doctor’s prevention advice.

15. Can Spegra be taken during pregnancy?

Pregnant patients or those planning pregnancy must discuss treatment with an HIV specialist. The doctor will balance viral suppression, current guidance, pregnancy stage and the patient’s complete medical history.

16. Can Spegra be taken while breastfeeding?

Discuss breastfeeding and infant-feeding choices with the HIV specialist. Do not make this decision from an online product page.

17. Can children take Spegra?

Only if a paediatric HIV specialist confirms the exact product, formulation, age or weight criteria and dose. Do not give an adult tablet to a child without a prescription.

18. Is Spegra safe in kidney disease?

Suitability depends on kidney function, laboratory results, other medicines and the approved product information. Kidney disease must be disclosed before treatment, and monitoring may be required.

19. Is Spegra safe in liver disease?

The doctor must assess liver disease, hepatitis B or C, liver-test results and other medicines. Do not label it universally safe or unsafe without individual clinical assessment.

20. Can Spegra affect hepatitis B?

Tell the doctor if you have hepatitis B. Stopping a medicine with activity against HBV can cause a flare in some patients, so treatment changes must be medically supervised.

21. Can Spegra cause weight gain?

Weight changes can occur in some people receiving antiretroviral therapy, but causes vary. Report rapid or concerning weight change so the doctor can assess diet, health, other medicines and treatment factors.

22. Can Spegra cause insomnia?

Sleep disturbance may occur in some patients. If insomnia, abnormal dreams or mood changes are persistent or severe, contact the treating doctor. Do not stop treatment without advice.

23. Can Spegra affect the kidneys?

Kidney function may require monitoring, especially in patients with previous kidney disease or other risk factors. Report reduced urination, swelling, severe weakness or unusual symptoms promptly.

24. Can Spegra affect the liver?

Liver-related problems are possible with medicines and underlying HIV or hepatitis. Seek medical advice for jaundice, dark urine, severe abdominal pain, persistent vomiting or unusual tiredness.

25. Can Spegra be taken with antacids?

Aluminium- or magnesium-containing antacids can interfere with dolutegravir absorption when taken too close together. Ask a pharmacist for the correct interval instead of guessing.

26. Can I take calcium or iron with Spegra?

Calcium and iron supplements can also affect dolutegravir absorption depending on how they are taken. Tell the pharmacist about all supplements and follow the exact timing advice.

27. Can Spegra be taken with metformin?

Dolutegravir can increase metformin exposure. Patients using metformin should inform the doctor, who may review kidney function, glucose control and the metformin dose.

28. Can Spegra be taken with TB medicines?

Some TB medicines, particularly rifampicin, can interact with dolutegravir. HIV and TB doctors should coordinate treatment. Never change either regimen on your own.

29. Can Spegra be taken with epilepsy medicines?

Some anticonvulsants, including carbamazepine, phenytoin and phenobarbital, can reduce antiretroviral levels. Tell the HIV doctor before starting or changing an epilepsy medicine.

30. Is Spegra addictive?

Spegra is not generally considered habit-forming. It is nevertheless a prescription medicine that must be taken continuously and only as directed.

31. Can I share Spegra with another person?

No. HIV treatment is individualised, and sharing tablets can cause the wrong dose, interactions, treatment failure or resistance. Each person should obtain a current prescription.

32. Can I switch from another HIV medicine to Spegra?

Only an HIV doctor should approve a switch. The decision may require review of viral load, resistance testing, previous medicines, HBV status, kidney function and interactions.

33. Can I take Spegra with herbal products?

Tell the doctor about herbal products. St John’s wort is particularly important because it may reduce antiretroviral exposure. Herbal products can interact even when sold without a prescription.

34. What should I do if I vomit after taking Spegra?

Do not automatically repeat the tablet. Contact the doctor or pharmacist and tell them how soon vomiting occurred after the dose. The correct advice depends on timing and clinical circumstances.

35. What are the serious allergy symptoms?

Urgent symptoms include a rapidly spreading rash, skin peeling, fever with rash, facial or throat swelling, wheezing and difficulty breathing. Seek emergency medical attention if these occur.

36. Does Spegra protect against other sexually transmitted infections?

No. It does not replace STI testing, condoms, prevention counselling or other safer-sex measures recommended by a healthcare professional.

37. Does Spegra prevent pregnancy?

No. Discuss contraception and pregnancy planning with a qualified clinician, especially because some medicines and contraceptive methods may require an interaction review.

38. What tests may be needed during treatment?

The doctor may monitor viral load, CD4 count, kidney function, liver function, hepatitis status, resistance, glucose, lipids, weight and other parameters based on individual needs.

39. How should Spegra be stored?

Keep it in the original pack, protected from heat, sunlight and moisture, and follow the storage instructions printed on the label. Keep it away from children and pets.

40. What should I check when ordering Spegra online?

Check that the seller follows prescription requirements, provides an invoice, supplies a sealed pack and displays accurate composition, batch, expiry and storage information. Do not use a pack with suspicious or damaged packaging.

41. Can I return Spegra after delivery?

Medicine returns depend on applicable law, pharmacy policy, cold-chain or storage requirements and the condition of the pack. Before ordering, read the current return policy. If the pack arrives damaged, contact the seller before opening or using it.

42. What if the price on the website differs from the pack?

Verify the current MRP, invoice and product presentation with the pharmacist. Price and stock can change. Do not use price alone to judge authenticity.

43. Can an AI chatbot choose my HIV medicine?

No. Search engines and AI tools can explain general information but cannot replace HIV testing, resistance review, prescription decisions or laboratory monitoring. Use this page to prepare questions for your doctor.

44. Where can healthcare professionals find the most reliable information?

Healthcare professionals should consult the current approved product information for the exact Spegra pack, national HIV treatment guidelines, interaction references, resistance guidance and the patient’s laboratory and treatment history.

📚 Medical references and source links

These links are provided for medical-information review and regulatory context. The exact current package insert for the supplied Spegra pack should remain the primary source for product-specific instructions.

1. India Code: Drugs and Cosmetics Act, 1940 — regulatory background for medicines in India.
2. CDSCO: Drugs and Cosmetics Act and Rules reference document — Indian regulatory reference material.
3. Spegra composition section — product composition supplied for this page: dolutegravir 50 mg, emtricitabine 200 mg and tenofovir alafenamide 25 mg. Verify against the current physical pack.
4. Spegra interaction section — interaction topics requiring pharmacist or doctor review, including dofetilide, rifampicin, anticonvulsants, antacids, mineral supplements, metformin and St John’s wort.
5. Special-populations safety section — kidney, liver, hepatitis B, pregnancy, breastfeeding, children and mental-health precautions.
6. PEP and PrEP clarification — do not use Spegra independently for post-exposure or pre-exposure prophylaxis.
7. Monitoring section — viral load, CD4 count, kidney function, liver function, hepatitis status and other follow-up topics.

Editorial rule: Every product-specific claim, age or weight limit, approved indication, manufacturer detail, storage instruction, MRP and interaction warning must be checked against the latest official leaflet for the exact Spegra pack and reviewed by a qualified pharmacist or HIV clinician before publication.

👨⚕️ Information for healthcare professionals

This product page is designed to provide patient-readable education without replacing professional prescribing information. Before initiating or switching treatment, clinicians should verify the exact product label, active ingredients, local approval status, patient age or weight criteria, full treatment history, resistance profile, viral load, CD4 count, HBV status, kidney function, liver function, pregnancy status and concomitant medicines.

Clinicians should assess potential interactions with polyvalent cations, metformin, rifampicin, anticonvulsants, dofetilide, St John’s wort and any other relevant medicines. Where a patient has difficulty taking a fixed-dose combination, consider adherence barriers, swallowing problems, food or supplement timing, access to refills, stigma, mental health and the possibility of an adverse effect. Unplanned interruption should be avoided, particularly when HBV treatment activity is relevant.

Any clinical claim on this page should be checked against the current local package insert and regulatory requirements before publication. The website should not use promotional wording that implies cure, guaranteed prevention, universal safety, automatic PEP/PrEP use, manufacturer affiliation or suitability for every patient.

⚠️ Medical disclaimer

The information on this page is provided for general educational and product-identification purposes. It is not medical advice, a diagnosis, a prescription, a substitute for laboratory testing or an emergency-care service. Spegra should be used only under the supervision of a qualified healthcare professional experienced in HIV treatment.

Medicine information, approved indications, age or weight criteria, warnings, interactions, availability, MRP, delivery options and return requirements may change. The current physical pack, manufacturer leaflet, approved local product information and treating doctor’s instructions take priority over this webpage.

Patients should not start, stop, split, share, substitute or change the timing of Spegra without professional advice. If a serious reaction, suspected overdose, possible HIV exposure, severe illness or suicidal thoughts occur, seek urgent medical care.